Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Germany’s Grand Coalition Offers Pharma Little Certainty, Except For Continued Discounts

This article was originally published in The Pink Sheet Daily

Executive Summary

Germany’s new grand coalition government includes a health minister with no background in health care.

You may also be interested in...

Sensing No Room For Price Compromise, Janssen Pulls Invokana From Germany

After a disappointing assessment from Germany’s two reimbursement bodies, Janssen has opted to withdraw it diabetes drug, believing it cannot secure a competitive price.

Reimbursement Deal In Germany Puts Forxiga Back On Medicine Menu

A deal struck between Germany’s health insurance funds and Astra Zeneca/Bristol Myers Squibb means the drug manufacturers are ready to start supplying the drug again to the country’s health service.

European Notebook: Price Freezes, European Elections To Feature In 2014

This month’s European Notebook scans the horizon for European legislative and regulatory changes affecting the pharmaceutical industry in the next 12 months, including drug price freezes in Germany and the U.K., the heated debate over clinical trial data transparency, the start of the EU unitary patent, and more.

Related Content


Related Companies




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts